Eden vs yourEra for weight loss
Eden and yourEra side by side: what each costs as your dose rises, which medications each prescribes, and the terms behind the price.
By the RxLineup editorial team · Fact-checked against provider sites and FDA labels · Updated
Only providers that pay us appear in our rankings and reviews, and we’re paid when you sign up through our links. How we make money
- Safety: GLP-1 medications carry a boxed warning for thyroid C-cell tumors. Read before you start
Higher score
Eden
Rated 9.1 out of 10, Excellent
From $99/mo
Tirzepatide $129/mo
yourEra
Rated 8.8 out of 10, Excellent
From $89/mo
Tirzepatide $99/mo
The verdict
YourEra charges less for compounded semaglutide ($65/mo, 12 mo prepaid, vs $99/mo); yourEra charges less for compounded tirzepatide ($99/mo, 12 mo prepaid, vs $129/mo). Only Eden offers Wegovy, Ozempic, Zepbound and Mounjaro. Eden scores higher overall (9.1 vs 8.8), with its widest lead on medication options (8.5 vs 6.5).
Choose Eden if…
You want the option of Wegovy, Ozempic, Zepbound or Mounjaro and a better medication options score (8.5 vs 6.5).
Choose yourEra if…
You want compounded semaglutide for $65/mo, compounded tirzepatide for $99/mo and a better experience score (10.0 vs 9.0).
What’s different
The six places where Eden and yourEra differ for weight loss, from the prices and terms each publishes.
| Difference | Eden | yourEra |
|---|---|---|
| Compounded semaglutide | $99/mo | $65/mo |
| Compounded tirzepatide | $129/mo | $99/mo |
| Wegovy | $1,794/mo | Not offered |
| Ozempic | $1,498/mo | Not offered |
| Zepbound | $1,498/mo | Not offered |
| Mounjaro | $1,498/mo | Not offered |
Head to head
| Feature | Eden review | yourEra review |
|---|---|---|
| Overall score | 9.1/10 Higher | 8.8/10 |
| Starting price | $99/mo | $89/mo Lower |
| Compounded semaglutide | $99/mo | $65/mo billed $780 for 12 months Lower |
| Compounded tirzepatide | $129/mo | $99/mo billed $1,188 for 12 months Lower |
| Brand-name options | Wegovy, Ozempic, Zepbound, Mounjaro | None |
| Same price at every dose | Yes | Yes |
| Membership | None | None |
| Insurance | Self-pay | Self-pay |
| Refunds | Weight Loss Warranty: follow your Eden plan for 6 months and, if you lose less than 15% of your body weight, you may qualify for your money back. Eligibility depends on plan adherence and required check-ins | Your card is charged only if a clinician prescribes, and you get a full refund if you cancel before the order ships |
| Availability | – | All 50 states (availability of specific treatments varies by state) |
| Next step | Visit Eden for Eden (opens in a new tab) | Visit yourEra for yourEra (opens in a new tab) |
– Not published by the provider.
Scores compared
Both programs are scored out of 10 on the same five weighted criteria. How we rate
EdenyourEra
-
Price & value 30%
-
Clinical care 25%
-
Medication options 20%
-
Transparency 15%
-
Experience 10%
Eden pros and cons
Strengths
- $99/mo semaglutide and $129/mo tirzepatide at every dose
- No membership fee or long-term contract on GLP-1 plans
- Weight Loss Warranty, and labwork when a provider orders it
- LegitScript seal; HSA/FSA eligible; free expedited shipping
Drawbacks
- Brand-name GLP-1s cost $1,399 to $1,695 a month plus a $99 membership
- Charges are non-refundable once filled, apart from the warranty
- Partner pharmacies other than Eden Pharmacy aren’t named
- No state list published
yourEra pros and cons
Strengths
- Semaglutide $65/month on the 12-month plan, $89 month to month
- Same price at every dose, renewing at the same rate
- Charged only if prescribed
- Pharmacies named in its terms; HSA/FSA eligible
Drawbacks
- Lowest price is billed yearly ($780)
- No refund once an order ships
- Compounded medication only
- Labs and coaching only in a membership listed as coming soon
Safety
One of these treatments carries an FDA boxed warning, the strongest warning on a label: GLP-1 medications.
- SemaglutideNot FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. FDA label
- TirzepatideNot FDA-approved
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. FDA label
- WegovyFDA-approved for long-term weight reduction (adults, and children 12 and older)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- OzempicFDA-approved drug; used off-label here
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- ZepboundFDA-approved for long-term weight reduction (adults)
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
- MounjaroFDA-approved drug; used off-label here
- GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2.
Not medical advice. A licensed clinician decides whether a treatment is right for you; read the full prescribing information before you start.
Not sure which program fits?
Answer five quick questions about budget, medication and insurance, and we’ll rank the programs for you. No email or sign-up needed.